Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors

Amanda C. Guidon, Leeann B. Burton, Bart K. Chwalisz, James Hillis, Teilo H. Schaller, Anthony A. Amato, Allison Betof Warner, Priscilla K. Brastianos, Tracey A. Cho, Stacey L. Clardy, Justine V. Cohen, Jorg Dietrich, Michael Dougan, Christopher T. Doughty, Divyanshu Dubey, Jeffrey M. Gelfand, Jeffrey T. Guptill, Douglas B. Johnson, Vern C. Juel, Robert KadishNoah Kolb, Nicole R. Leboeuf, Jenny Linnoila, Andrew L. Mammen, Maria Martinez-Lage, Meghan J. Mooradian, Jarushka Naidoo, Tomas G. Neilan, David A. Reardon, Krista M. Rubin, Bianca D. Santomasso, Ryan J. Sullivan, Nancy Wang, Karin Woodman, Leyre Zubiri, William C. Louv, Kerry L. Reynolds

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences